Pfizer CFO Dave Denton goes Inside the ICE House to discuss how the company is navigating its post‑COVID transition and positioning itself for a return to sustainable growth later this decade. He details Pfizer’s major strategic investments in oncology and metabolic health, including the Seagen and Metsera deals, and explains how proven platforms, global scale, and financial discipline are central to those moves. Denton also shares how execution, patient‑centric innovation, and emerging technologies like AI are shaping the next chapter of Pfizer’s growth story.

Market Storylines: Earnings Strength, Geopolitical Crosscurrents + Powell's Swan Song

Inside the ICE House, a podcast produced by Intercontinental Exchange, takes listeners behind the historic façade of the New York Stock Exchange and inside the global financial marketplace. The episodes, recorded in the Library of the NYSE, features conversations with leaders, entrepreneurs and visionaries who walk through our doors with a dream of building businesses and changing the world. Their stories have made the NYSE, now part of ICE’s ecosystem of markets, clearing houses, data provider, and listings services, an indispensable institution for over 225 years.